US09075A1088
US09075A1088
Bioventus Inc.
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 892.41M EUR | 643.92M EUR | 617.54M EUR | 499.21M EUR |
Enterprise Value | 1.15B EUR | 862.91M EUR | 853.77M EUR | 741.92M EUR |
Valuation Multiples | ||||
Trailing P/E | 16.75x | 11.82x | 21.68x | 19.68x |
Forward P/E | 14.2x | -- | -- | -- |
Price to Sales | 1.53x | 1.11x | 1.07x | 1.12x |
Price to Book | 3.9x | 2.82x | 3.27x | 2.71x |
EV/Revenue | 1.98x | 1.48x | 1.48x | 1.67x |
EV/EBITDA | 14.34x | 8.11x | 8.03x | 8.65x |
Price to FCF (P/FCF) | 13.17x | 6.83x | 6.14x | 5.41x |
EV/FCF | 16.96x | 9.15x | 8.48x | 8.04x |
FCF Yield | 7.59% | 14.64% | 16.29% | 18.48% |